
Marea
Operator of a biotechnology company intended for the treatment of cardiometabolic diseases. The company specializes in the development of novel therapies for patients at risk for heart attacks, enabli...
Valuation
$272M
Latest known
Share Price
N/A
Total Raised
$190M
Last Round
N/A